Panitumumab - an effective long-term treatment for patients with metastatic colorectal cancer and wild-type KRAS status.
Elez
Elena
E
Medical Oncology Department, Vall d'Hebron University Hospital, P. Vall d'Hebron, Barcelona, Spain.
Alsina
Maria
M
Tabernero
Josep
J
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D018450:Disease Progression; D006801:Humans; D000077544:Panitumumab; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras); D016879:Salvage Therapy / Q000379:methods; D018631:ras Proteins / Q000235:genetics*
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; C117307:KRAS protein, human; D011518:Proto-Oncogene Proteins; D000077544:Panitumumab; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins